Monitoring Parameters Beyond Glycemic Control: Impact of Sitagliptin on Quality of Life in Type 2 Diabetes Patients
Clinical trial NCT05167513 · COMPLETED
Trial details
- NCT number
- NCT05167513
- Sponsor
- Getz Pharma
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-01
- Primary completion
- 2022-04-28
- Enrollment
- 188
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.